Celltrion Healthcare recently signed an agreement with Libertyville, IL-based CarePartners Pharmacy to sell its Humira biosimilar Yuflyma in the U.S. market
The FTC is expanding its ongoing study on pharmacy benefit managers (PBMs) and their impact on the accessibility and affordability of prescription drugs
Combined with a number of recent acquisitions and ongoing consolidation by market participants, we view the primary care market undergoing a major transformation over the next few years.
The latest in specialty pharmacy news and research. Stay up to date on companies and industry trends at the forefront of the specialty pharmacy industry.
AMI’s new report, Primary Care Providers: Evolving in 2023-2024 provides a background of the primary care market and profiles the companies that will be leading the market in 2023 and beyond
QOL Medical Selects Optum Frontier Therapies as New Pharmacy Partner for Sucraid® to support CSID patients nationwide being treated with Sucraid® (sacrosidase) Oral Solution
RightwayRx Offers Employers An Alternative to the Big 3 PBMs
Optum Specialty Fusion™ was launched to streamline treatment decision-making for care providers, helping patients get on their therapies faster